Companies

Angus Russell, CEO of Shire: full interview

Angus Russell, chief executive of Shire, the UK drugs group, talks to Andrew Jack, pharmaceuticals correspondent, about Pfizer, R&D in the UK, and why high prices can still be charged for orphan drugs.